The dark side of a tumor suppressor:: anti-apoptotic p53

被引:152
作者
Janicke, R. U. [1 ]
Sohn, D. [1 ]
Schulze-Osthoff, K. [1 ]
机构
[1] Univ Dusseldorf, Inst Mol Med, D-40225 Dusseldorf, Germany
关键词
apoptosis; DNA repair; oxidative stress; survival pathways; transcription factor; tumorigenesis;
D O I
10.1038/cdd.2008.33
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Depending on multiple factors DNA damage leads either to cell cycle arrest or apoptosis. One of the main players deciding the fate of a cell is the tumor suppressor p53 that modulates these responses in a transcription-dependent and -independent manner. Over the past few years, however, strong evidence accumulated that p53 engages also powerful pro-survival pathways by transcriptionally activating a multitude of genes whose products efficiently counteract apoptosis. Our review summarizes the current knowledge concerning approximately forty p53-regulated proteins that exert their anti-apoptotic potential by interfering with diverse cellular processes. These activities are surely essential for normal development and maintenance of a healthy organism, but may easily turn into the dark side of the tumor suppressor p53 contributing to tumorigenesis.
引用
收藏
页码:959 / 976
页数:18
相关论文
共 173 条
[1]   Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol γ [J].
Achanta, G ;
Sasaki, R ;
Feng, L ;
Carew, JS ;
Lu, WQ ;
Pelicano, H ;
Keating, MJ ;
Huang, P .
EMBO JOURNAL, 2005, 24 (19) :3482-3492
[2]   Role of p53 in sensing oxidative DNA damage in response to reactive oxygen species-generating agents [J].
Achanta, G ;
Huang, P .
CANCER RESEARCH, 2004, 64 (17) :6233-6239
[3]   p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene [J].
Adimoolam, S ;
Ford, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) :12985-12990
[4]  
ALVES F, 1995, ONCOGENE, V10, P609
[5]   Netrin-1 and its receptors in tumorigenesis [J].
Arakawa, H .
NATURE REVIEWS CANCER, 2004, 4 (12) :978-987
[6]   MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].
BARAK, Y ;
JUVEN, T ;
HAFFNER, R ;
OREN, M .
EMBO JOURNAL, 1993, 12 (02) :461-468
[7]   Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB [J].
Benoit, V. ;
de Moraes, E. ;
Dar, N. A. ;
Taranchon, E. ;
Bours, V. ;
Hautefeuille, A. ;
Taniere, P. ;
Chariot, A. ;
Scoazec, J-Y ;
Gallo, C. V. de Moura ;
Merville, M-P ;
Hainaut, P. .
ONCOGENE, 2006, 25 (42) :5708-5718
[8]   TIGAR, a p53-inducible regulator of glycolysis and apoptosis [J].
Bensaad, Karim ;
Tsuruta, Atsushi ;
Selak, Mary A. ;
Calvo Vidal, M. Nieves ;
Nakano, Katsunori ;
Bartrons, Ramon ;
Gottlieb, Eyal ;
Vousden, Karen H. .
CELL, 2006, 126 (01) :107-120
[9]   p53 from complexity to simplicity: mutant p53 stabilization, gain-of-function, and dominant-negative effect [J].
Blagosklonny, MV .
FASEB JOURNAL, 2000, 14 (13) :1901-1907
[10]   Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion [J].
Bourdon, Alice ;
Minai, Limor ;
Serre, Valerie ;
Jais, Jean-Philippe ;
Sarzi, Emmanuelle ;
Aubert, Sophie ;
Chretien, Dominique ;
de Lonlay, Pascale ;
Paquis-Flucklinger, Veronique ;
Arakawa, Hirofumi ;
Nakamura, Yusuke ;
Munnich, Arnold ;
Rotig, Agnes .
NATURE GENETICS, 2007, 39 (06) :776-780